Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
about
Progestin effects on cell proliferation pathways in the postmenopausal mammary glandLong term hormone therapy for perimenopausal and postmenopausal womenBias in Observational Studies of the Association between Menopausal Hormone Therapy and Breast CancerEstrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the RiskMenopausal hormone therapy and breast cancer mortality: clinical implicationsPrescribing menopausal hormone therapy: an evidence-based approachLong-term hormone therapy for perimenopausal and postmenopausal women.Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy.Histologic changes in the breast with menopausal hormone therapy use: correlation with breast density, estrogen receptor, progesterone receptor, and proliferation indicesMenstrual cycle-related exacerbation of diseaseOccult breast tumor reservoir: biological properties and clinical significance.Tissue selective estrogen complex combinations with bazedoxifene/conjugated estrogens as a model.Ductal carcinoma in situ of the breast: a surgical perspective.Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males.Absence of the proapoptotic Bax protein extends fertility and alleviates age-related health complications in female mice.Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data.Ongoing data from the breast cancer prevention trials: opportunity for breast cancer risk reduction.IMS reaction to recent breast cancer data.Premature ovarian failure: a review.Data analysis methods and the reliability of analytic epidemiologic researchEVITA: a tool for the early evaluation of pharmaceutical innovations with regard to therapeutic advantagePostmenopausal estrogen and progestin effects on the serum proteome.Endometrial profile of tamoxifen and low-dose estradiol combination therapy.Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects.Obesity, gynecological factors, and abnormal mammography follow-up in minority and medically underserved womenIn Perspective: Estrogen Therapy Proves to Safely and Effectively Reduce Total Mortality and Coronary Heart Disease in Recently Postmenopausal WomenEstrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy.Detection of Actaea racemosa adulteration by thin-layer chromatography and combined thin-layer chromatography-bioluminescence.Effects of 17β-estradiol on proliferation, cell viability and intracellular redox status in native human lens epithelial cellsBody mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials.Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profilingConjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial.On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy useLung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.The 2012 hormone therapy position statement of: The North American Menopause Society.Chains of evidence, mosaics of data: does estrogen 'cause' breast cancer? How would we know?Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects
P2860
Q21092903-7BB19108-1522-44A4-89ED-E92FFE8B5223Q24201974-8F495DB9-0B9A-42F7-9B4C-A8366D2F971CQ24288665-8E0C2FAE-533A-4405-A2C1-290B1DFD1E92Q24658109-0441CF31-0CF6-4798-9046-95EC16514905Q26821782-E37DEF36-3252-4AAA-8853-E0F66889AA4FQ27022201-0F560748-4B02-44A2-AEF3-5E193D42F87FQ27022920-F9F80DF9-70CF-430F-9D36-12508E918B18Q30238978-804B2A9F-1162-4C20-9A58-603D47066743Q30370779-47A64FE6-658D-46D0-B956-CF64A18326A6Q30370870-E8B3FCFD-A59C-41B4-83A5-58C6590A8549Q30431992-7E0D1E40-8852-4692-9007-4165F08CA13EQ30456637-4B2E3B1B-A026-49B9-911F-280E237B2A63Q30456770-7A412220-18F1-4815-9546-937E7CB0BAF7Q30463534-F4FB1CEB-9BFB-46A8-98DD-DE2DA93D815EQ30474007-BF320697-55B2-4A5E-99E4-62E2F56AF8B2Q30479070-6E21A945-7413-4BE5-89C7-9643E19CF251Q30659580-C16A33E5-E08C-45BD-BBA7-74AD7F09F8ADQ30936399-64269298-EB77-42A4-8151-9AC0BC10E263Q31105720-71E4AD49-F85F-4B95-8E61-DF5E92C26A84Q33278956-0251EA23-8BCE-4A8F-ABFF-C4701A80B061Q33371496-074F7A38-B8E7-4036-AF23-CFD55E0EB127Q33541294-87E53AC0-329D-4919-A276-D31D28F9AD3AQ33600109-BB4B07DF-BE78-47A0-9BB0-B685CF0D97F1Q33638802-3AC5497C-CA9E-459F-9A5A-528500D60ECBQ33739861-E81ADF50-A555-442B-898D-F22FA632D5CDQ33775333-7142BD1A-2B7C-49A1-AF96-0DF6E937ED5FQ33862138-E0D4941E-EF11-4BD7-90A1-FA7598D53D6FQ33898159-DE9FE1B2-D645-404E-A9E2-701144F7B2D9Q33970926-AA43C660-680A-4B62-AF6C-F9156ADB7ADFQ33995503-FA868D48-47AA-4597-9776-8D98FCD15A21Q34039907-DB1FFF05-CF8C-47B1-A517-AADEB7EEC382Q34073510-3E1517A4-646C-4008-AFB9-36E83B53C4ABQ34118386-793F0449-F4FE-4032-9EC0-FB3559566399Q34120300-5AA979E9-E309-4E33-B8A6-58AD0884D1D3Q34131826-7E421913-3B04-43A2-B90C-0D15C3946CBBQ34145853-7DC8B4B0-96F5-418C-AE57-A61829E74457Q34161400-4984AFF7-DCB1-448D-8648-3424EF0CCBEAQ34285969-C0AFF1E9-6CE7-4278-B56F-684F9C6C5137Q34315478-F80E32C9-9C98-46D4-80A7-82A439EC6CF4Q34317537-BCE6D9B4-3D52-4421-8C7D-D4E85FAD4A21
P2860
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Effects of conjugated equine e ...... ausal women with hysterectomy.
@ast
Effects of conjugated equine e ...... ausal women with hysterectomy.
@en
Effects of conjugated equine e ...... ausal women with hysterectomy.
@nl
type
label
Effects of conjugated equine e ...... ausal women with hysterectomy.
@ast
Effects of conjugated equine e ...... ausal women with hysterectomy.
@en
Effects of conjugated equine e ...... ausal women with hysterectomy.
@nl
prefLabel
Effects of conjugated equine e ...... ausal women with hysterectomy.
@ast
Effects of conjugated equine e ...... ausal women with hysterectomy.
@en
Effects of conjugated equine e ...... ausal women with hysterectomy.
@nl
P2093
P356
P1476
Effects of conjugated equine e ...... pausal women with hysterectomy
@en
P2093
Annlouise R Assaf
Dorothy S Lane
Electra D Paskett
F Allan Hubbell
Gloria E Sarto
Lawrence Lessin
Marcia L Stefanick
Rebecca J Rodabough
Robert S Schenken
Rowan T Chlebowski
P304
P356
10.1001/JAMA.295.14.1647
P407
P577
2006-04-01T00:00:00Z